EcoDrugPlus

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSNFUG00015006023
Gene Symbol: TUBB2
1 Cross references
305 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSNFUG00015011873
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSNFUG00015001875
Gene Symbol: TP53
3 Cross references
232 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSNFUG00015020863
Gene Symbol: TYR
1 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSNFUG00015003600
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSNFUG00015018175
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSNFUG00015006968
Gene Symbol: TYK2
1 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSNFUG00015025290
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSNFUG00015024039
Gene Symbol: LOC107394328
3 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSNFUG00015005410
Gene Symbol: LOC107384206
3 Cross references
195 Possible Orthologues:

Utrophin

Ensembl ID : ENSNFUG00015003325
Gene Symbol: UTRN
1 Cross references
270 Possible Orthologues:

V-Akt Murine Thymoma Viral Oncogene Homolog 2

Ensembl ID : ENSNFUG00015020511
Gene Symbol: AKT2
1 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).